Melatonin from Plants: Going Beyond Traditional Central Nervous System Targeting – A Comprehensive Review of its Unusual Health Benefits
Authors:
- Lucas Fornari LaurindoLucas Fornari Laurindo
- Otávio SimilliOSOtávio Similli
- Adriano Cressoni AraújoAAAdriano Cressoni Araújo
- Elen Landgraf GuiguerEGElen Landgraf Guiguer
- Rosa DireitoRosa Direito
- Vitor Engrácia ValentiVVVitor Engrácia Valenti
- Vitor de OliveiraVOVitor de Oliveira
- Juliana de OliveiraJOJuliana de Oliveira
- José Luiz Yanaguizawa JuniorJJJosé Luiz Yanaguizawa Junior
- Jefferson DiasJDJefferson Dias
- Durvanei Augusto MariaDMDurvanei Augusto Maria
- Rose Eli Grassi RiciRRRose Eli Grassi Rici
Preprint
- 7 January 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Melatonin was primarily identified for its indispensable roles in animals. Recently, it has been described as a potent regulator of several physiological pathways in plants. In humans, it has shown effects in the prevention or as an adjuvant treatment for several diseases mainly related to the immune system, inflammation, and oxidative stress. Moreover, a melatonin-rich diet is linked to several health benefits, such as regulation of the circadian rhythm, regulation of the immunological system, epilepsy control, reduced allergic reactions, delaying the aging process, diminishing hormones related to cancer, and delaying Alzheimer’s and Parkinson’s disease symptoms. This review aimed to show the effects of melatonin in diseases beyond its traditional use. The outcome of clinical trials showed that it can present scavenging of free radicals (reducing reactive oxygen species) and inflammation (reducing the synthesis of inflammatory cytokines modulating the immune system. Moreover, it can minimize apoptosis, insulin resistance, blood pressure, LDL-c, body mass index, adipose tissue mass, waist circumference, adhesion molecules, endothelial impairment, plaque formation, and muscle atrophy. It can also reduce hyperleptinemia, alanine aminotransferase, and liver fat. These effects result in neuro and cardioprotection, improvement of liver diseases, rheumatoid arthritis, dermatitis, COVID-19, polycystic ovaries, dermatitis, and sepsis. We conclude that plant melatonin can benefit patients with many diseases besides sleep problems and neurodegeneration. Plant melatonin may also be more cost-effective, less adverse, and more sustainable than synthetic; therefore, it is better than the typical already sold. However, more clinical trials should show adequate doses, formulation, and treatment time.Keywords
All Related Versions
- Version 1, 2025-01-07, Preprints
- Published version: Biology, 14 (2), 143.
This publication has 145 references indexed in Scilit:
- Melatonin as a Chronobiotic and Cytoprotector in Non-communicable Diseases: More than an Antioxidant2024
- Innovative public strategies in response to COVID‐19: A review of practices from ChinaHealth Care Science, 2024
- Assessing the antiviral potential of melatonin: A comprehensive systematic reviewReviews in Medical Virology, 2023
- Melatonin supplementation protects against traumatic colon injury by regulating SERPINA3N protein expressioniMeta, 2023
- Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospectsOsteoporosis International, 2023
- Melatonin supplementation improves N‐terminal pro‐B‐type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trialClinical Cardiology, 2022
- Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factorsDiabetes/Metabolism Research and Reviews, 2021
- Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double‐blinded clinical trialClinical Cardiology, 2021
- Ischemic stroke, obesity, and the anti‐inflammatory role of melatoninBioFactors, 2020
- Melatonin Supplementation for Children With Atopic Dermatitis and Sleep DisturbanceJAMA Pediatrics, 2016